International Conference on Neuro Oncology and Brain Tumor July 21-22, 2016 Brisbane, Australia

safdfgghmjnhbvcxzxcvbnmn dsgtrrhh

eftetrtreg

Prof. Michael Friebe, PhD, has been involved in diagnostic imaging and image guided therapeutic products and services, as founder / innovator / CEO investor, and scientist. Dr. Friebe currently is a Board Member of two startup R&D companies, as well as investment partner of a medical technology startup-fund. He is an affiliated professor with the chair for Computer Aided Medical Procedures (CAMP) at TU München, and full professor of Image Guided Therapies at the Otto-von-Guericke-University in Magdeburg, Germany. He is listed inventor of more than 60 patent applications and the author of numerous papers.

Neuro imaging

Paola Marmiroli was born in Milan in 1960. In 1984 she graduated in Medicine (110/110 cum laude) and in 1988 she boarded in Neurology. From 1989 to 2001 clinical position as neurologist at the Neurological Department of the General Hospital of Vimercate. Since April 2001 Assistant Professor in Human Anatomy at the School of Medicine of the University of Milan “Bicocca” . Teaching: Anatomy and Histology for medical students (MD Program) and for Bachelor’s degree in Nursing and Midwifery. Neuroanatomy for Residency Program in Neurology and Neuropsychiatry Research activity: Morphological studies in the field of neuroanatomy, immunohistochemical studies in peripheral nervous system pathology, research in neurotoxicity of anticancer drugs in animal models. She is author of about 55 papers on international peer-reviewed journals.

Bruno Giometto, MD, is the director of Dept. of Neurology in Padova and was coordinator of the PNS Euronetwork. He has published more than 80 papers in peer-reviewed journals. He is Vice-President of the Italian Neurological Society.

Dr. Sun Jin Kim received MD in 1986 and PhD in 1993 from the College of Medicine and the Graduate School of Seoul National University. He completed the residency in the Seoul National University Hospital and postdoctoral fellowship in the University of Texas MD Anderson Cancer Center. He was an invited scientist in the National Cancer Center Research Institute, Tokyo, Japan. He is a professor in the Department of Cancer Biology, UTMDACC and has published more than 80 papers in peer-reviewed journals. He has been involved in clinical translational research programs developing the clinical trials of novel molecules and protocols.

Joya Chandra, Ph.D., is an Associate Professor at the University of Texas MD Anderson Cancer Center. Research in her lab is directed towards understanding the basis for sensitivity and resistance to cancer therapeutics and optimizing their use. She has published on this topic for the past 15 years. Several of her recent publications have described the mechanism of action of epigenetically targeted agents such as histone deacetylase inhibitors, either as single agents or in combination with other therapies. She has authored over 50 original research papers, invited reviews and book chapters.

Dr. Aizenberg is an Associate Professor of Neurosurgery at the University of Nebraska Medical Center. She is Board Certified by the American Board of Neurological Surgery. Dr. Aizenberg has completed fellowship training in Neurosurgical Oncology at The University of Texas M. D. Anderson Cancer Center and has a special interest in primary and metastatic tumors of the brain and spine. Utilizing special imaging and surgical techniques, Dr. Aizenberg is able to resect tumors in eloquent areas of the brain in ways to help prevent neurologic deficits. By individualized care, the best approach is determined for each patient so that they have maximal outcome. She works closely with radiation oncologists, neuro-oncologists, oncologists, neuroradiologists, neuropathologists, and neuropsychologists to provide the most comprehensive care for oncology patients. With this multi-disciplinary approach, comprehensive Neuro-Oncology care can be provided for patients with central nervous system tumors. With this in mind, Dr. Aizenberg was instrumental in establishing the Brain and Spine Cancer Center (BASCC) at the Nebraska Medical Center. In 2009, she was named the Director of the BASCC.

Guido Cavaletti, MD, is a certified neurologist since 1990. He is the Head of the Experimental Neurology Unit at the University of Milano-Bicocca and has a long-lasting experience in the preclinical and clinical assessment of CIPN. He has published more than 200 full papers in peer-reviewed journals, he is is consulted by the FDA, NIH and EMA and has been serving as associate editor of the Journal of the Peripheral Nervous System and as editorial board member of Experimental neurology and Current medicinal Chemistry.

Nancy Ratner, PhD, is interested in understanding mechanisms of peripheral nerve tumor (neurofibroma) formation in neurofibromatosis type 1 (NF1), a common inherited disorder in which children are predisposed to cancer of the nervous system, to learning problems, bone disorders, and other cancers. She identified EGFR and MEK as potential therapeutic targets in NF1 peripheral nerve tumorigenesis, and has developed cell culture and mouse models of NF1 nerve tumorigenesis. Her laboratory has also used analysis of gene expression to identify critical genes in neurofibroma and their malignant derivatives, MPNST. Dr. Ratner received her bachelor's from Brown University, her doctorate from Indiana University, and was a postdoctoral fellow at Washington University in St. Louis. She was a member of the faculty at the University of Cincinnati from 1987 to 2004. Dr. Ratner is currently a professor in the Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, and the program leader for Cancer Biology and Neural Tumors Program in the Cancer and Blood Diseases Institute where she holds the Beatrice C. Lampkin Endowed chair in cancer biology and serves as PI of the NINDS P50 “Cincinnati Center in NF Research.” Dr. Ratner is an active member of the International Consortium on the Molecular Biology of NF1, NF2, and Schwannomatosis and was a member of the advisory board for the National Neurofibromatosis Foundation (now Children’s Tumor Foundation) from 1989 to 2007. She chaired the Department of Defense Neurofibromatosis Research Program Integration Panel in 2008, and currently serves as a member of the James McDonnell Brain Tumor Research Advisory Board. She received the von Recklinghausen Award from the Children’s Tumor Foundation in 2010 and the Jacob K. Javits Neuroscience Investigator Award (NIH-NINDS MERIT Award) in 2014.